Adaptive Sampling Advances Pediatric Cancer Profiling - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Adaptive Sampling Advances Pediatric Cancer Profiling

  • November 16, 2026

  • 3 min

Share

  • 1

    Researchers evaluated adaptive sampling whole-genome sequencing in 36 samples from 35 pediatric patients, including 31 tumor samples.

  • 2

    Compared with conventional testing, the assay detected all 20 known gene fusions, mutations in 58 of 59 affected genes, and 20 of 21 large copy-number alterations.

  • 3

    Within 24 hours, all 20 gene fusions and 47 mutations with variant allele frequencies above 25% had at least five supporting reads; large chromosomal alterations appeared within an hour.

  • 4

    Methylation analysis correctly classified 9 of 11 acute lymphoblastic leukemia samples and 8 of 12 solid tumors, without separate testing.

  • 5

    Estimated sequencing costs were approximately CAD $1,700 per sample versus more than CAD $5,000 for combined conventional approaches; further clinical validation is needed.

Original Source(s)

Related Content